Cargando…

Intra-Tumoral Delivery of IL-27 Using Adeno-Associated Virus Stimulates Anti-tumor Immunity and Enhances the Efficacy of Immunotherapy

IL-27 is an anti-inflammatory cytokine that has been shown to have potent anti-tumor activity. We recently reported that systemic delivery of IL-27 using recombinant adeno-associated virus (rAAV) induced depletion of Tregs and significantly enhanced the efficacy of cancer immunotherapy in a variety...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Aiyan, Ding, Miao, Zhu, Jianmin, Liu, Jin-Qing, Pan, Xueliang, Ghoshal, Kalpana, Bai, Xue-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118910/ https://www.ncbi.nlm.nih.gov/pubmed/32292786 http://dx.doi.org/10.3389/fcell.2020.00210

Ejemplares similares

The Half-Life-Extended IL21 can Be Combined With Multiple Checkpoint Inhibitors for Tumor Immunotherapy
por: Wu, Shaoxian, et al.
Publicado: (2021)

Lipid metabolism and tumor immunotherapy
por: Wang, Yue, et al.
Publicado: (2023)

Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy
por: Xiao, Chu, et al.
Publicado: (2022)

Application of CRISPR screen in mechanistic studies of tumor development, tumor drug resistance, and tumor immunotherapy
por: Li, Min, et al.
Publicado: (2023)

Non-immune Cell Components in the Gastrointestinal Tumor Microenvironment Influencing Tumor Immunotherapy
por: Li, Zhengshuo, et al.
Publicado: (2021)

Peritoneal resident macrophages in tumor metastasis and immunotherapy
por: Zhang, Yu, et al.
Publicado: (2022)

Towards Immunotherapy-Induced Normalization of the Tumor Microenvironment
por: Melo, Vinicio, et al.
Publicado: (2022)

Tumor-Associated Extracellular Matrix: How to Be a Potential Aide to Anti-tumor Immunotherapy?
por: He, Yingying, et al.
Publicado: (2021)

Editorial: Tissue-resident immune cells in tumor immunity and immunotherapy
por: Del Prete, Annalisa, et al.
Publicado: (2022)

Function and clinical application of exosome—how to improve tumor immunotherapy?
por: Qin, Siwen, et al.
Publicado: (2023)

Editorial: Immune modulation in tumor microenvironment: New perspectives for cancer immunotherapy
por: Deng, Zimu, et al.
Publicado: (2023)

IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy
por: Romaniello, Donatella, et al.
Publicado: (2023)

The Identification of the Metabolism Subtypes of Skin Cutaneous Melanoma Associated With the Tumor Microenvironment and the Immunotherapy
por: Yang, Ronghua, et al.
Publicado: (2021)

Expression Patterns of Glycosylation Regulators Define Tumor Microenvironment and Immunotherapy in Gastric Cancer
por: Li, Fang, et al.
Publicado: (2022)

Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma
por: Yu, Chenhang, et al.
Publicado: (2022)

Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy
por: Shi, Houhui, et al.
Publicado: (2021)

DNA Methylation Modification Map to Predict Tumor Molecular Subtypes and Efficacy of Immunotherapy in Bladder Cancer
por: Ye, Fangdie, et al.
Publicado: (2021)

The Pan-Cancer Crosstalk Between the EFNA Family and Tumor Microenvironment for Prognosis and Immunotherapy of Gastric Cancer
por: Xie, Rongrong, et al.
Publicado: (2022)

Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer
por: Cao, Xi, et al.
Publicado: (2022)

Differential Role of PD-1 Expressed by Various Immune and Tumor Cells in the Tumor Immune Microenvironment: Expression, Function, Therapeutic Efficacy, and Resistance to Cancer Immunotherapy
por: Kim, Myeong Joon, et al.
Publicado: (2021)

Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment
por: Wu, Peijie, et al.
Publicado: (2021)

Tumor-Derived Exosomes Modulate Primary Site Tumor Metastasis
por: Bai, Suwen, et al.
Publicado: (2022)

Characterization of Molecular Heterogeneity Associated With Tumor Microenvironment in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy
por: Zhong, Weimin, et al.
Publicado: (2021)

The Crosstalk Between Malignant Cells and Tumor-Promoting Immune Cells Relevant to Immunotherapy in Pancreatic Ductal Adenocarcinoma
por: Liu, Xuefei, et al.
Publicado: (2022)

Multi-Omics Analysis of Novel Signature for Immunotherapy Response and Tumor Microenvironment Regulation Patterns in Urothelial Cancer
por: Chu, Guangdi, et al.
Publicado: (2021)

Evaluating DNA Methylation, Gene Expression, Somatic Mutation, and Their Combinations in Inferring Tumor Tissue-of-Origin
por: Liu, Haiyan, et al.
Publicado: (2021)

Crosstalk between the CBM complex/NF-κB and MAPK/P27 signaling pathways of regulatory T cells contributes to the tumor microenvironment
por: Qi, Tongbing, et al.
Publicado: (2022)

Dual effects of radiotherapy on tumor microenvironment and its contribution towards the development of resistance to immunotherapy in gastrointestinal and thoracic cancers
por: Zhao, Deyao, et al.
Publicado: (2023)

The miRNA Profile of Inflammatory Colorectal Tumors Identify TGF-β as a Companion Target for Checkpoint Blockade Immunotherapy
por: Bartlett, Bjarne, et al.
Publicado: (2021)

Pan-Cancer Study on Protein Kinase C Family as a Potential Biomarker for the Tumors Immune Landscape and the Response to Immunotherapy
por: Abdelatty, Alaa, et al.
Publicado: (2022)

Multi-Omics Characterization of Tumor Microenvironment Heterogeneity and Immunotherapy Resistance Through Cell States–Based Subtyping in Bladder Cancer
por: Hu, Rixin, et al.
Publicado: (2022)

AZD5153, a Bivalent BRD4 Inhibitor, Suppresses Hepatocarcinogenesis by Altering BRD4 Chromosomal Landscape and Modulating the Transcriptome of HCC Cells
por: Lin, Cho-Hao, et al.
Publicado: (2022)

Apoptin as a Tumor-Specific Therapeutic Agent: Current Perspective on Mechanism of Action and Delivery Systems
por: Malla, Waseem Akram, et al.
Publicado: (2020)

LCK and CD3E Orchestrate the Tumor Microenvironment and Promote Immunotherapy Response and Survival of Muscle-Invasive Bladder Cancer Patients
por: Zheng, Xiaonan, et al.
Publicado: (2021)

Eomes Impedes Durable Response to Tumor Immunotherapy by Inhibiting Stemness, Tissue Residency, and Promoting the Dysfunctional State of Intratumoral CD8(+) T Cells
por: Sun, Runzi, et al.
Publicado: (2021)

The mutation in splicing factor genes correlates with unfavorable prognosis, genomic instability, anti-tumor immunosuppression and increased immunotherapy response in pan-cancer
por: Luo, Jiangti, et al.
Publicado: (2023)

Hypermethylation of DHRS3 as a Novel Tumor Suppressor Involved in Tumor Growth and Prognosis in Gastric Cancer
por: Sumei, Sha, et al.
Publicado: (2021)

Tipping the Scales With Zebrafish to Understand Adaptive Tumor Immunity
por: Miao, Kelly Z., et al.
Publicado: (2021)

Tumor-Derived Lactate Creates a Favorable Niche for Tumor via Supplying Energy Source for Tumor and Modulating the Tumor Microenvironment
por: Jin, Mengyao, et al.
Publicado: (2022)

Gut Microbiota Signatures in Tumor, Para-Cancerous, Normal Mucosa, and Feces in Colorectal Cancer Patients
por: Li, Yanmin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tnk60tqphrff5pj9jlkhrfl4hk